Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Patients Receiving Chemotherapy for Pancreatic Cancer

NCT04600154 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04600154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04600154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Patients Receiving Chemotherapy for Pancreatic Cancer
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 10, 2021
Completion date
June 30, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia, chemotherapy effect, pancreatic cancer